Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 16, 2012 08:40 ET | Source: Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics Announces the Pricing of Public Offering of Common Stock

CARMIEL, Israel, Feb. 16, 2012 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE Amex:PLX) (TASE:PLX), announced today the pricing of its previously announced underwritten public offering of...
February 15, 2012 16:15 ET | Source: Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics Announces Proposed Public Offering of Common Stock

CARMIEL, Israel, Feb. 15, 2012 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE Amex:PLX) (TASE:PLX) announced today that it intends, subject to market conditions, to offer and sell shares of...
February 09, 2012 02:00 ET | Source: Protalix BioTherapeutics, Inc.

Protalix Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network Symposium

CARMIEL, Israel, Feb. 9, 2012 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE AMEX:PLX) (TASE:PLX), announced today that new clinical data on taliglucerase alfa will be presented at the 8th...
January 26, 2012 02:00 ET | Source: Protalix BioTherapeutics, Inc.

Protalix Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network Symposium

CARMIEL, Israel, Jan. 26, 2012 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE Amex:PLX) (TASE:PLX), announced today that new clinical data on taliglucerase alfa will be presented at the 8th...
December 13, 2011 16:15 ET | Source: Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics to Present at the Oppenheimer 22nd Annual Healthcare Conference

CARMIEL, Israel, Dec. 13, 2011 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE Amex:PLX) (TASE:PLX), announced today that Dr. David Aviezer, the Company's President and Chief Executive...